2010 Annual Meeting

Session: Model Based QbD in Drug Substance or Drug Product

This session invites presentations in which response models have been developed from measured data for operations in drug substance or drug product development. These models may result from statistical design of experiments, a mechanistic / first principles approach, or a combination of the two. Submissions that address model verification are particularly welcome, for example using separate model development and model verification data sets.

Chair

Schild, R., Bristol-Myers Squibb

Co-Chair

Nere, N. K., Abbott Laboratories